$XOS Earnings Preview: Recent $XOS Insider Trading, Hedge Fund Activity, and More

$XOS ($XOS) is expected to release its quarterly earnings data on Wednesday, March 19th after market close, per Finnhub. Analysts are expecting revenue of $17,964,536 and earnings of -$1.20 per share.

You can see Quiver Quantitative's $XOS stock page to track data on insider trading, hedge fund activity, congressional trading, and more.

$XOS Insider Trading Activity

$XOS insiders have traded $XOS stock on the open market 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.

Here’s a breakdown of recent trading of $XOS stock by insiders over the last 6 months:

• CHRISTEN T ROMERO (General Counsel) sold 20,000 shares for an estimated $80,004
• LIANA POGOSYAN (Acting Chief Financial Officer) sold 7,418 shares for an estimated $28,695

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$XOS Hedge Fund Activity

We have seen 9 institutional investors add shares of $XOS stock to their portfolio, and 11 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• UBS GROUP AG removed 4,111 shares (-14.7%) from their portfolio in Q4 2024, for an estimated $13,319
• GEODE CAPITAL MANAGEMENT, LLC removed 1,741 shares (-4.3%) from their portfolio in Q4 2024, for an estimated $5,640
• OSAIC HOLDINGS, INC. removed 180 shares (-41.7%) from their portfolio in Q4 2024, for an estimated $583
• ASPIRE PRIVATE CAPITAL, LLC removed 153 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $495
• MORGAN STANLEY added 100 shares (+17.4%) to their portfolio in Q4 2024, for an estimated $324
• BANK OF AMERICA CORP /DE/ added 85 shares (+7.5%) to their portfolio in Q4 2024, for an estimated $275
• WELLS FARGO & COMPANY/MN removed 77 shares (-98.7%) from their portfolio in Q4 2024, for an estimated $249

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.